You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ibritumomab Tiuxetan

Showing 1 - 25 of 97
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial in Houston (Ibritumomab Tiuxetan (Zevalin), Rituximab)

Completed
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 30, 2022

GVHD, Leukemia, Lymphoma Trial in Duarte (biological, drug, procedure, radiation, other)

Active, not recruiting
  • Graft Versus Host Disease
  • +2 more
  • rituximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Lymphoma Trial in United Kingdom (biological, drug, radiation)

Terminated
  • Lymphoma
  • rituximab
  • +5 more
  • Manchester, England, United Kingdom
  • +4 more
Dec 16, 2021

Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

Active, not recruiting
  • Ann Arbor Stage I Grade 1 Follicular Lymphoma
  • +9 more
  • Quality-of-Life Assessment
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 3, 2022

Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

Active, not recruiting
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • rituximab
  • +7 more
  • Sacramento, California
    University of California Davis
Nov 28, 2022

Lymphoma Trial (biological, drug, procedure, radiation)

Completed
Has Results
  • Lymphoma
  • filgrastim
  • +4 more
  • (no location specified)
Jun 16, 2021

Zevalin Post-marketing Surveillance in Japan

Completed
  • Non-Hodgkin's Lymphoma (NHL)
  • [90]Y-ibritumomab tiuxetan (Zevalin, BAY86-5128)
  • Multiple Locations, Japan
    (unnamed)
Sep 30, 2021

Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)

Completed
Has Results
  • Lymphoma, Follicular
  • Scarborough, Maine
  • +3 more
Apr 27, 2021

Lymphoma Trial in New York, Houston (biological, drug, radiation)

Completed
Has Results
  • Lymphoma
  • darbepoetin alfa
  • +8 more
  • New York, New York
  • +1 more
Oct 19, 2020

Non-Hodgkin's Lymphoma Trial in United States (Y-90-Zevalin, Moxtezafin Gadolinium, Rituximab)

Terminated
Has Results
  • Non-Hodgkin's Lymphoma
  • Berkeley, California
  • +8 more
Sep 6, 2021

Lymphoma Trial in United States (biological, drug, radiation)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +7 more
  • Anchorage, Alaska
  • +47 more
Dec 22, 2021

Primary CNS Non-Hodgkin Lymphoma Trial in Cleveland (rituximab, yttrium Y 90 ibritumomab tiuxetan)

Terminated
Has Results
  • Primary Central Nervous System Non-Hodgkin Lymphoma
  • rituximab
  • yttrium Y 90 ibritumomab tiuxetan
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 23, 2020

Follicular Lymphoma Trial in United States (Zevalin, Rituximab)

Terminated
Has Results
  • Follicular Lymphoma
  • Sun City, Arizona
  • +4 more
Sep 6, 2021

Follicular Lymphoma, Lymphoma, Follicular Trial in United States (Zevalin Therapeutic Regimen, R-CVP)

Terminated
Has Results
  • Follicular Lymphoma
  • Lymphoma, Follicular
  • Zevalin Therapeutic Regimen
  • R-CVP
  • Jacksonville, Florida
  • +5 more
Dec 16, 2021

Non-Hodgkin's Lymphoma Trial in Madison (Ibritumomab Tiuxetan (Zevalin) + Rituximab)

Terminated
Has Results
  • Non-Hodgkin's Lymphoma
  • Ibritumomab Tiuxetan (Zevalin) + Rituximab
  • Madison, Wisconsin
    University Of Wisconsin
Dec 11, 2019

Lymphoma Trial in Spain (Rituximab, Ibritumomab tiuxetan)

Completed
  • Lymphoma
  • Alcorcón, Spain
  • +20 more
Apr 27, 2020

Non-Hodgkin's Lymphoma Trial in Worldwide (ibritumomab tiuxetan, BEAM chemo and autologous stem-cell transplantation)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • ibritumomab tiuxetan
  • BEAM chemotherapy and autologous stem-cell transplantation
  • Scottsdale, Arizona
  • +8 more
Aug 13, 2020

Follicular Non-Hodgkin's Lymphoma Trial in Italy (R-CHOP or R-bendamustine, Observation, Maintenance weekly x4)

Active, not recruiting
  • Follicular Non-Hodgkin's Lymphoma
  • R-CHOP or R-bendamustine
  • +4 more
  • Meldola, Forlì Cesena, Italy
  • +47 more
Dec 29, 2021

Relapsed Follicular Lymphoma Trial in Italy (ZEVALIN, BEAM)

Active, not recruiting
  • Relapsed Follicular Lymphoma
  • Genova, GE, Italy
  • +37 more
Dec 22, 2022

Leukemia, Lymphoma Trial in Houston (Rituximab, 111In Ibritumomab, Planar Scintigraphy Imaging)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2020

Lymphoma Trial in Tucson (Methylprednisolone, Etoposide, Cytarabine)

Completed
Has Results
  • Lymphoma
  • Tucson, Arizona
    The University of Arizona Cancer Center
Aug 23, 2019

Lymphoma Trial in Atlanta, Chicago (rituximab, bortezomib, Ibritumomab tiuxetan)

Terminated
Has Results
  • Lymphoma
  • Atlanta, Georgia
  • +1 more
Aug 23, 2019

Follicular Lymphoma Trial in France, United Kingdom (90Y Ibritumomab tiuxetan, Rituximab)

Completed
  • Follicular Lymphoma
  • Lille, France
  • +6 more
Oct 11, 2019

Diffuse Large B-cell Lymphoma, Follicle Center Lymphoma Trial in Worldwide (Zevalin, Y-90-Zevalin, Rituximab)

Terminated
Has Results
  • Diffuse Large B-cell Lymphoma
  • Follicle Center Lymphoma
  • Casa Grande, Arizona
  • +92 more
Nov 18, 2021

Lymphoma, Large Cell, Diffuse Trial in Worldwide (Zevalin)

Terminated
Has Results
  • Lymphoma, Large Cell, Diffuse
  • Mesa, Arizona
  • +89 more
Jan 17, 2022